Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for BPTF
Z-value: 1.68
Motif logo
Transcription factors associated with BPTF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BPTF | hg19_v2_chr17_+_65821636_65821641 | 0.46 | 2.0e-02 | Click! |
Activity profile of BPTF motif
Sorted Z-values of BPTF motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr7_-_150329421 | 6.47 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
| chr4_-_159080806 | 5.60 |
ENST00000590648.1
|
FAM198B
|
family with sequence similarity 198, member B |
| chr4_+_156588115 | 5.51 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_-_186877806 | 5.49 |
ENST00000355634.5
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr4_+_41614909 | 4.73 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr3_-_112127981 | 4.73 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
| chr4_+_156587979 | 3.98 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_+_156588249 | 3.91 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_+_156587853 | 3.73 |
ENST00000506455.1
ENST00000511108.1 |
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_+_41614720 | 3.47 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr9_+_2157655 | 3.25 |
ENST00000452193.1
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr9_+_75766763 | 2.93 |
ENST00000456643.1
ENST00000415424.1 |
ANXA1
|
annexin A1 |
| chr19_+_11200038 | 2.88 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
| chr4_-_186696425 | 2.66 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr13_-_20357110 | 2.65 |
ENST00000427943.1
|
PSPC1
|
paraspeckle component 1 |
| chr8_+_97597148 | 2.57 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
| chr4_-_90759440 | 2.44 |
ENST00000336904.3
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr9_-_80437915 | 2.41 |
ENST00000397476.3
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
| chr8_+_9046503 | 2.33 |
ENST00000512942.2
|
RP11-10A14.5
|
RP11-10A14.5 |
| chr1_-_45452240 | 2.21 |
ENST00000372183.3
ENST00000372182.4 ENST00000360403.2 |
EIF2B3
|
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
| chr4_+_41540160 | 2.20 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr13_-_20357057 | 2.19 |
ENST00000338910.4
|
PSPC1
|
paraspeckle component 1 |
| chr1_+_153746683 | 2.19 |
ENST00000271857.2
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
| chr9_+_2158443 | 2.16 |
ENST00000302401.3
ENST00000324954.5 ENST00000423555.1 ENST00000382186.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr3_-_149051444 | 2.16 |
ENST00000296059.2
|
TM4SF18
|
transmembrane 4 L six family member 18 |
| chr18_+_48918368 | 2.12 |
ENST00000583982.1
ENST00000578152.1 ENST00000583609.1 ENST00000435144.1 ENST00000580841.1 |
RP11-267C16.1
|
RP11-267C16.1 |
| chr17_-_5321549 | 2.10 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
| chr16_-_30032610 | 2.08 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
| chr9_-_14313641 | 2.05 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
| chr9_+_2158485 | 2.04 |
ENST00000417599.1
ENST00000382185.1 ENST00000382183.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr4_-_186697044 | 2.02 |
ENST00000437304.2
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr4_+_26585538 | 1.97 |
ENST00000264866.4
|
TBC1D19
|
TBC1 domain family, member 19 |
| chr9_-_47314222 | 1.97 |
ENST00000420228.1
ENST00000438517.1 ENST00000414020.1 |
AL953854.2
|
AL953854.2 |
| chr5_+_139027877 | 1.96 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr4_+_26585686 | 1.94 |
ENST00000505206.1
ENST00000511789.1 |
TBC1D19
|
TBC1 domain family, member 19 |
| chr2_-_190445499 | 1.84 |
ENST00000261024.2
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1 |
| chr2_-_36779411 | 1.83 |
ENST00000406220.1
|
AC007401.2
|
Uncharacterized protein |
| chr4_-_89152474 | 1.82 |
ENST00000515655.1
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 |
| chr8_-_27941380 | 1.81 |
ENST00000413272.2
ENST00000341513.6 |
NUGGC
|
nuclear GTPase, germinal center associated |
| chr2_-_238499303 | 1.81 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
| chr2_+_33359646 | 1.77 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr8_+_29952914 | 1.76 |
ENST00000321250.8
ENST00000518001.1 ENST00000520682.1 ENST00000442880.2 ENST00000523116.1 |
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
| chrX_-_62571187 | 1.75 |
ENST00000335144.3
|
SPIN4
|
spindlin family, member 4 |
| chr17_+_7384721 | 1.75 |
ENST00000412468.2
|
SLC35G6
|
solute carrier family 35, member G6 |
| chr11_-_33891362 | 1.74 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr6_+_144904334 | 1.74 |
ENST00000367526.4
|
UTRN
|
utrophin |
| chr10_-_116286656 | 1.74 |
ENST00000428430.1
ENST00000369266.3 ENST00000392952.3 |
ABLIM1
|
actin binding LIM protein 1 |
| chr9_+_75136717 | 1.73 |
ENST00000297784.5
|
TMC1
|
transmembrane channel-like 1 |
| chr2_+_33359687 | 1.72 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr9_-_14313893 | 1.72 |
ENST00000380921.3
ENST00000380959.3 |
NFIB
|
nuclear factor I/B |
| chr21_+_17961006 | 1.68 |
ENST00000602323.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr9_+_40028620 | 1.66 |
ENST00000426179.1
|
AL353791.1
|
AL353791.1 |
| chr1_-_100231349 | 1.65 |
ENST00000287474.5
ENST00000414213.1 |
FRRS1
|
ferric-chelate reductase 1 |
| chr15_+_55611128 | 1.63 |
ENST00000164305.5
ENST00000539642.1 |
PIGB
|
phosphatidylinositol glycan anchor biosynthesis, class B |
| chr2_+_201980827 | 1.62 |
ENST00000309955.3
ENST00000443227.1 ENST00000341222.6 ENST00000355558.4 ENST00000340870.5 ENST00000341582.6 |
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr18_+_20513782 | 1.61 |
ENST00000399722.2
ENST00000399725.2 ENST00000399721.2 ENST00000583594.1 |
RBBP8
|
retinoblastoma binding protein 8 |
| chr10_-_116286563 | 1.60 |
ENST00000369253.2
|
ABLIM1
|
actin binding LIM protein 1 |
| chr15_+_66585555 | 1.60 |
ENST00000319194.5
ENST00000525134.2 ENST00000441424.2 |
DIS3L
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
| chr3_+_141105705 | 1.55 |
ENST00000513258.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr9_+_27109392 | 1.54 |
ENST00000406359.4
|
TEK
|
TEK tyrosine kinase, endothelial |
| chr8_-_99129338 | 1.52 |
ENST00000520507.1
|
HRSP12
|
heat-responsive protein 12 |
| chr1_-_114301503 | 1.52 |
ENST00000447664.2
|
PHTF1
|
putative homeodomain transcription factor 1 |
| chr9_-_13279406 | 1.51 |
ENST00000546205.1
|
MPDZ
|
multiple PDZ domain protein |
| chr8_-_17942432 | 1.51 |
ENST00000381733.4
ENST00000314146.10 |
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
| chr18_-_53303123 | 1.50 |
ENST00000569357.1
ENST00000565124.1 ENST00000398339.1 |
TCF4
|
transcription factor 4 |
| chr9_-_111775772 | 1.49 |
ENST00000325580.6
ENST00000374593.4 ENST00000374595.4 ENST00000325551.4 |
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1 |
| chr4_-_110723194 | 1.49 |
ENST00000394635.3
|
CFI
|
complement factor I |
| chr10_+_35484053 | 1.45 |
ENST00000487763.1
ENST00000473940.1 ENST00000488328.1 ENST00000356917.5 |
CREM
|
cAMP responsive element modulator |
| chr13_-_114843416 | 1.45 |
ENST00000389544.4
|
RASA3
|
RAS p21 protein activator 3 |
| chr2_+_132286754 | 1.44 |
ENST00000434330.1
|
CCDC74A
|
coiled-coil domain containing 74A |
| chr17_+_66521936 | 1.41 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr17_-_62097927 | 1.40 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
| chr7_+_44663908 | 1.38 |
ENST00000543843.1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
| chr4_-_90758118 | 1.36 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr9_+_116267536 | 1.35 |
ENST00000374136.1
|
RGS3
|
regulator of G-protein signaling 3 |
| chr5_-_61031495 | 1.35 |
ENST00000506550.1
ENST00000512882.2 |
CTD-2170G1.2
|
CTD-2170G1.2 |
| chrX_-_62571220 | 1.35 |
ENST00000374884.2
|
SPIN4
|
spindlin family, member 4 |
| chr9_+_2159850 | 1.34 |
ENST00000416751.1
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr9_+_72002837 | 1.34 |
ENST00000377216.3
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr19_+_58281014 | 1.33 |
ENST00000391702.3
ENST00000598885.1 ENST00000598183.1 ENST00000396154.2 ENST00000599802.1 ENST00000396150.4 |
ZNF586
|
zinc finger protein 586 |
| chr8_-_99129384 | 1.31 |
ENST00000521560.1
ENST00000254878.3 |
HRSP12
|
heat-responsive protein 12 |
| chr7_+_102553430 | 1.31 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
| chr8_-_17555164 | 1.30 |
ENST00000297488.6
|
MTUS1
|
microtubule associated tumor suppressor 1 |
| chr8_-_17579726 | 1.30 |
ENST00000381861.3
|
MTUS1
|
microtubule associated tumor suppressor 1 |
| chr2_-_183291741 | 1.30 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr17_-_295730 | 1.30 |
ENST00000329099.4
|
FAM101B
|
family with sequence similarity 101, member B |
| chr5_+_73109339 | 1.30 |
ENST00000296799.4
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28 |
| chrX_+_66764375 | 1.29 |
ENST00000374690.3
|
AR
|
androgen receptor |
| chr2_-_188312971 | 1.29 |
ENST00000410068.1
ENST00000447403.1 ENST00000410102.1 |
CALCRL
|
calcitonin receptor-like |
| chr10_+_94590910 | 1.28 |
ENST00000371547.4
|
EXOC6
|
exocyst complex component 6 |
| chr3_+_152017924 | 1.28 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr13_+_114239588 | 1.27 |
ENST00000544902.1
ENST00000408980.2 ENST00000453989.1 |
TFDP1
|
transcription factor Dp-1 |
| chr10_-_33623564 | 1.27 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
| chr21_+_17566643 | 1.27 |
ENST00000419952.1
ENST00000445461.2 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr21_-_27945562 | 1.26 |
ENST00000299340.4
ENST00000435845.2 |
CYYR1
|
cysteine/tyrosine-rich 1 |
| chr5_+_139028510 | 1.26 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
| chr4_-_90758227 | 1.26 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr9_+_71986182 | 1.25 |
ENST00000303068.7
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr3_-_93692781 | 1.24 |
ENST00000394236.3
|
PROS1
|
protein S (alpha) |
| chr17_-_62084241 | 1.24 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr3_+_141106458 | 1.23 |
ENST00000509883.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr5_-_94417314 | 1.22 |
ENST00000505208.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
| chr18_-_22932080 | 1.22 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
| chr9_-_39288092 | 1.21 |
ENST00000323947.7
ENST00000297668.6 ENST00000377656.2 ENST00000377659.1 |
CNTNAP3
|
contactin associated protein-like 3 |
| chr7_-_33140498 | 1.20 |
ENST00000448915.1
|
RP9
|
retinitis pigmentosa 9 (autosomal dominant) |
| chr4_+_90823130 | 1.18 |
ENST00000508372.1
|
MMRN1
|
multimerin 1 |
| chr21_-_27543425 | 1.17 |
ENST00000448388.2
|
APP
|
amyloid beta (A4) precursor protein |
| chr12_+_56915713 | 1.15 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
| chr3_+_57882024 | 1.15 |
ENST00000494088.1
|
SLMAP
|
sarcolemma associated protein |
| chr9_+_71939488 | 1.14 |
ENST00000455972.1
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr6_-_30712313 | 1.14 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
| chr14_-_54955721 | 1.13 |
ENST00000554908.1
|
GMFB
|
glia maturation factor, beta |
| chr19_+_19976683 | 1.12 |
ENST00000592725.1
|
ZNF253
|
zinc finger protein 253 |
| chr1_-_1677358 | 1.12 |
ENST00000355439.2
ENST00000400924.1 ENST00000246421.4 |
SLC35E2
|
solute carrier family 35, member E2 |
| chr16_-_49890016 | 1.11 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
| chr7_+_74072288 | 1.11 |
ENST00000443166.1
|
GTF2I
|
general transcription factor IIi |
| chr11_+_114168085 | 1.10 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr4_+_144303093 | 1.10 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
| chr12_+_29376673 | 1.10 |
ENST00000547116.1
|
FAR2
|
fatty acyl CoA reductase 2 |
| chr19_-_14640005 | 1.10 |
ENST00000596853.1
ENST00000596075.1 ENST00000595992.1 ENST00000396969.4 ENST00000601533.1 ENST00000598692.1 |
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr10_+_8096631 | 1.08 |
ENST00000379328.3
|
GATA3
|
GATA binding protein 3 |
| chr4_+_170581213 | 1.08 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
| chr22_-_29107919 | 1.07 |
ENST00000434810.1
ENST00000456369.1 |
CHEK2
|
checkpoint kinase 2 |
| chr12_+_29376592 | 1.07 |
ENST00000182377.4
|
FAR2
|
fatty acyl CoA reductase 2 |
| chrX_-_117119243 | 1.07 |
ENST00000539496.1
ENST00000469946.1 |
KLHL13
|
kelch-like family member 13 |
| chr7_+_150434430 | 1.06 |
ENST00000358647.3
|
GIMAP5
|
GTPase, IMAP family member 5 |
| chr6_-_41888843 | 1.05 |
ENST00000434077.1
ENST00000409312.1 |
MED20
|
mediator complex subunit 20 |
| chr5_-_111091948 | 1.05 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
| chr4_+_157997273 | 1.05 |
ENST00000541722.1
ENST00000512619.1 |
GLRB
|
glycine receptor, beta |
| chr9_+_92219919 | 1.05 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
| chr20_-_17539456 | 1.05 |
ENST00000544874.1
ENST00000377868.2 |
BFSP1
|
beaded filament structural protein 1, filensin |
| chr5_+_74011328 | 1.04 |
ENST00000513336.1
|
HEXB
|
hexosaminidase B (beta polypeptide) |
| chr7_-_38670957 | 1.04 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
| chr3_-_27764190 | 1.04 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
| chr18_-_52989525 | 1.03 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
| chr2_+_208423840 | 1.03 |
ENST00000539789.1
|
CREB1
|
cAMP responsive element binding protein 1 |
| chr6_-_133119668 | 1.02 |
ENST00000275227.4
ENST00000538764.1 |
SLC18B1
|
solute carrier family 18, subfamily B, member 1 |
| chr18_-_52989217 | 1.02 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
| chr19_-_14785622 | 1.02 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr7_-_38671098 | 1.02 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
| chr2_-_101767715 | 1.01 |
ENST00000376840.4
ENST00000409318.1 |
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain) |
| chr18_-_53089723 | 1.01 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
| chr3_+_132036243 | 1.01 |
ENST00000475741.1
ENST00000351273.7 |
ACPP
|
acid phosphatase, prostate |
| chr19_+_11658655 | 1.00 |
ENST00000588935.1
|
CNN1
|
calponin 1, basic, smooth muscle |
| chr19_-_14785698 | 1.00 |
ENST00000344373.4
ENST00000595472.1 |
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr4_+_78079450 | 1.00 |
ENST00000395640.1
ENST00000512918.1 |
CCNG2
|
cyclin G2 |
| chr19_-_14785674 | 1.00 |
ENST00000253673.5
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr19_-_49540073 | 0.99 |
ENST00000301407.7
ENST00000601167.1 ENST00000604577.1 ENST00000591656.1 |
CGB1
CTB-60B18.6
|
chorionic gonadotropin, beta polypeptide 1 Choriogonadotropin subunit beta variant 1; Uncharacterized protein |
| chr16_-_68034470 | 0.99 |
ENST00000412757.2
|
DPEP2
|
dipeptidase 2 |
| chr11_+_63998006 | 0.98 |
ENST00000355040.4
|
DNAJC4
|
DnaJ (Hsp40) homolog, subfamily C, member 4 |
| chr9_-_13175823 | 0.98 |
ENST00000545857.1
|
MPDZ
|
multiple PDZ domain protein |
| chr2_-_208489275 | 0.98 |
ENST00000272839.3
ENST00000426075.1 |
METTL21A
|
methyltransferase like 21A |
| chr17_+_80517216 | 0.97 |
ENST00000531030.1
ENST00000526383.2 |
FOXK2
|
forkhead box K2 |
| chr19_+_11708229 | 0.97 |
ENST00000361113.5
|
ZNF627
|
zinc finger protein 627 |
| chr15_+_35270552 | 0.97 |
ENST00000391457.2
|
AC114546.1
|
HCG37415; PRO1914; Uncharacterized protein |
| chr21_-_27462351 | 0.97 |
ENST00000448850.1
|
APP
|
amyloid beta (A4) precursor protein |
| chr3_+_57881966 | 0.97 |
ENST00000495364.1
|
SLMAP
|
sarcolemma associated protein |
| chr14_+_37667230 | 0.95 |
ENST00000556451.1
ENST00000556753.1 ENST00000396294.2 |
MIPOL1
|
mirror-image polydactyly 1 |
| chr3_-_72496035 | 0.95 |
ENST00000477973.2
|
RYBP
|
RING1 and YY1 binding protein |
| chr1_+_10290822 | 0.94 |
ENST00000377083.1
|
KIF1B
|
kinesin family member 1B |
| chr12_+_10365404 | 0.94 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
| chr11_-_82745238 | 0.94 |
ENST00000531021.1
|
RAB30
|
RAB30, member RAS oncogene family |
| chr16_+_3068393 | 0.93 |
ENST00000573001.1
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr6_+_25992884 | 0.93 |
ENST00000606723.2
|
U91328.19
|
U91328.19 |
| chr9_-_135230336 | 0.93 |
ENST00000224140.5
ENST00000372169.2 ENST00000393220.1 |
SETX
|
senataxin |
| chr16_+_77756399 | 0.93 |
ENST00000564085.1
ENST00000268533.5 ENST00000568787.1 ENST00000437314.3 ENST00000563839.1 |
NUDT7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
| chr2_+_203879568 | 0.92 |
ENST00000449802.1
|
NBEAL1
|
neurobeachin-like 1 |
| chr4_-_104021009 | 0.91 |
ENST00000509245.1
ENST00000296424.4 |
BDH2
|
3-hydroxybutyrate dehydrogenase, type 2 |
| chr12_+_51318513 | 0.91 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
| chr7_+_79765071 | 0.91 |
ENST00000457358.2
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
| chr19_-_23869970 | 0.91 |
ENST00000601010.1
|
ZNF675
|
zinc finger protein 675 |
| chr12_-_95044309 | 0.91 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr11_-_63376013 | 0.91 |
ENST00000540943.1
|
PLA2G16
|
phospholipase A2, group XVI |
| chr17_-_62097904 | 0.90 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr10_+_8096769 | 0.90 |
ENST00000346208.3
|
GATA3
|
GATA binding protein 3 |
| chr6_-_13328050 | 0.90 |
ENST00000420456.1
|
TBC1D7
|
TBC1 domain family, member 7 |
| chr9_-_3469181 | 0.90 |
ENST00000366116.2
|
AL365202.1
|
Uncharacterized protein |
| chr4_-_110723134 | 0.90 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
| chr7_+_93551011 | 0.89 |
ENST00000248564.5
|
GNG11
|
guanine nucleotide binding protein (G protein), gamma 11 |
| chr17_+_66511540 | 0.89 |
ENST00000588188.2
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr6_+_35996859 | 0.88 |
ENST00000472333.1
|
MAPK14
|
mitogen-activated protein kinase 14 |
| chr9_-_14180778 | 0.88 |
ENST00000380924.1
ENST00000543693.1 |
NFIB
|
nuclear factor I/B |
| chr10_+_119301928 | 0.88 |
ENST00000553456.3
|
EMX2
|
empty spiracles homeobox 2 |
| chr2_+_219246746 | 0.88 |
ENST00000233202.6
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
| chr1_+_145524891 | 0.88 |
ENST00000369304.3
|
ITGA10
|
integrin, alpha 10 |
| chr3_+_141144963 | 0.87 |
ENST00000510726.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr3_+_112051994 | 0.87 |
ENST00000473539.1
ENST00000315711.8 ENST00000383681.3 |
CD200
|
CD200 molecule |
| chr11_+_94822968 | 0.86 |
ENST00000278505.4
|
ENDOD1
|
endonuclease domain containing 1 |
| chr11_+_63997750 | 0.86 |
ENST00000321685.3
|
DNAJC4
|
DnaJ (Hsp40) homolog, subfamily C, member 4 |
| chrX_-_24045303 | 0.86 |
ENST00000328046.8
|
KLHL15
|
kelch-like family member 15 |
| chr6_-_159240415 | 0.85 |
ENST00000367075.3
|
EZR
|
ezrin |
| chr12_-_102455846 | 0.85 |
ENST00000545679.1
|
CCDC53
|
coiled-coil domain containing 53 |
| chr4_+_78079570 | 0.85 |
ENST00000509972.1
|
CCNG2
|
cyclin G2 |
| chr3_-_122512619 | 0.84 |
ENST00000383659.1
ENST00000306103.2 |
HSPBAP1
|
HSPB (heat shock 27kDa) associated protein 1 |
| chr11_+_114128522 | 0.84 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr5_-_10249990 | 0.84 |
ENST00000511437.1
ENST00000280330.8 ENST00000510047.1 |
FAM173B
|
family with sequence similarity 173, member B |
| chr3_-_101232019 | 0.84 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
| chr15_-_83837983 | 0.83 |
ENST00000562702.1
|
HDGFRP3
|
Hepatoma-derived growth factor-related protein 3 |
| chr17_+_58018269 | 0.83 |
ENST00000591035.1
|
RP11-178C3.1
|
Uncharacterized protein |
| chr16_+_8806800 | 0.83 |
ENST00000561870.1
ENST00000396600.2 |
ABAT
|
4-aminobutyrate aminotransferase |
Network of associatons between targets according to the STRING database.
First level regulatory network of BPTF
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 17.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 1.2 | 3.5 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 1.0 | 5.1 | GO:2000470 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.9 | 2.7 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.7 | 2.9 | GO:1905167 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.7 | 4.7 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.5 | 1.0 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.5 | 2.0 | GO:0072204 | pro-T cell differentiation(GO:0002572) cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.5 | 2.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 | 1.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 1.3 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.4 | 2.1 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.4 | 2.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.4 | 2.0 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 1.1 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 | 3.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 1.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.3 | 2.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.3 | 1.0 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.3 | 1.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.3 | 1.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.3 | 3.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.3 | 0.9 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.3 | 1.7 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.3 | 9.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 | 1.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 0.8 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.3 | 1.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 0.8 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 | 0.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 | 1.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.3 | 1.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 0.8 | GO:2000979 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.2 | 2.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.2 | 0.7 | GO:0036146 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.2 | 1.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
| 0.2 | 0.7 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.2 | 2.1 | GO:0000056 | ribosomal large subunit export from nucleus(GO:0000055) ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 1.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 0.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 2.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 | 1.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 0.8 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.2 | 1.9 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.2 | 1.0 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.2 | 1.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.6 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.2 | 1.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 1.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 | 2.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 0.8 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.2 | 1.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.6 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.2 | 0.6 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 | 2.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.2 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 0.5 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.2 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 | 0.7 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.2 | 1.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 1.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 0.5 | GO:0086100 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
| 0.2 | 1.0 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.2 | 0.7 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.2 | 2.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.2 | 1.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 | 1.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 0.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 0.3 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.2 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 | 0.5 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.2 | 1.7 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 0.8 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.2 | 0.6 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.2 | 0.5 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.1 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.1 | 1.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.1 | 2.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 | 0.3 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 1.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.1 | 3.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.7 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 | 0.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 2.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 0.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 1.7 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 1.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 | 1.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 1.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 1.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.1 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.1 | 0.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.1 | 0.2 | GO:0048633 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.1 | 0.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.3 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.7 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.4 | GO:2000819 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) regulation of restriction endodeoxyribonuclease activity(GO:0032072) regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.4 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.7 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 | 0.3 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 0.1 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
| 0.1 | 0.3 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 0.4 | GO:0097384 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular lipid biosynthetic process(GO:0097384) |
| 0.1 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 | 0.3 | GO:0018032 | protein amidation(GO:0018032) |
| 0.1 | 0.4 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 1.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 0.2 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 | 0.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 1.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.5 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.1 | 0.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 0.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 | 0.2 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.1 | 0.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.1 | 1.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 1.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.3 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.1 | 0.3 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 0.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 | 0.8 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.1 | GO:0035905 | atrial septum primum morphogenesis(GO:0003289) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.1 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.1 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 1.7 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 1.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.1 | 1.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
| 0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.1 | 0.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.1 | 0.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 1.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.1 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 1.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 8.9 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 1.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.1 | 0.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 | 0.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 1.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 0.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.0 | 0.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
| 0.0 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.0 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.2 | GO:1902617 | cellular response to cold(GO:0070417) response to fluoride(GO:1902617) |
| 0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.0 | 1.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.0 | 0.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 | 0.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 | 0.2 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.0 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.0 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.0 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.0 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.0 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 4.8 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
| 0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.0 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.0 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
| 0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 1.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 1.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.0 | 0.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.0 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 | 0.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.0 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.0 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.0 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.8 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.3 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
| 0.0 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 | 0.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.0 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 1.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.0 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 | 1.0 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
| 0.0 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 | 1.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.0 | 0.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.0 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 2.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 | 0.2 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.0 | 0.2 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.0 | 6.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 | 0.5 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.0 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.0 | 0.3 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
| 0.0 | 0.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.0 | 0.1 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.0 | 1.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.0 | 0.5 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.1 | GO:0018012 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.0 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 | 0.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 6.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |